Blog

//Blog

Future of the Cancer Treatments

Ayala #Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer #Treatments December 06, 2017 09:30 AM Eastern Standard Time REHOVOT, Israel--(BUSINESS WIRE)--Ayala Pharmaceuticals, a #biopharmaceutical company dedicated to developing targeted #cancer therapies, announced today that they have entered into an exclusive worldwide [...]

By | 2017-12-07T10:56:48+00:00 December 7th, 2017|Blog|Comments Off on Future of the Cancer Treatments

UK company wins global #medicine #award for its ground-breaking potential MS #treatment

NOVEMBER 07, 2017 A leading scientist battling to halt the development of Multiple Sclerosis has revealed that clinical human trials will start by 2020, after her company was honoured with a major nano medicine award. Dr Su Metcalfe's regenerative nanomedicine company, LIFNano™, was named Most Promising Nanomedicine Project at the International Nano Medicine Awards in Berlin on Tuesday, [...]

By | 2017-12-06T15:53:01+00:00 December 6th, 2017|Blog|Comments Off on UK company wins global #medicine #award for its ground-breaking potential MS #treatment

Atox Bio closes $30M round as it speeds through late-stage trials

by brittany meiling — on December 4, 2017 09:06 AM EST Israel’s Atox Bio has raised $30 million — the latest in a long line of equity deals — to help push its #immune #modulators through late-stage clinical trials. The company is working on immune modulators for patients with severe infections and tissue injury. The company’s lead drug, called Reltecimod, is [...]

By | 2017-12-05T10:45:24+00:00 December 5th, 2017|Blog|Comments Off on Atox Bio closes $30M round as it speeds through late-stage trials

#Israel-based DiA Imaging inks deal with GE #Healthcare on #ultrasound #devices

by Joseph Keenan | Nov 20, 2017 9:49am DiA Imaging inks deal with GE Healthcare on ultrasound device software development. #DiAImagingAnalysis, a #medical imaging #software company based in Israel, has inked a deal with GE #Healthcare to develop automated imaging analysis technology.  The deal is a multiyear, nonexclusive licensing and professional services arrangement, the company said. Financial terms weren’t [...]

By | 2017-11-21T10:57:56+00:00 November 21st, 2017|Blog|Comments Off on #Israel-based DiA Imaging inks deal with GE #Healthcare on #ultrasound #devices

Forgetting to take your meds? Israeli firm creates nudging tool

Vaica launches Capsuled, a device that gives audio and visual reminders to patients on chronic medication By TOI STAFF13 November 2017, 4:13 pm Vaica's Capsuled, a cloud-connected, drug-distribution device to make sure medications are taken on time (Courtesy) For patients suffering from such life-threatening illnesses as #cancer, chronic lung diseases or #HIV, #medication #regimens can be [...]

By | 2017-11-16T11:35:27+00:00 November 16th, 2017|Blog|Comments Off on Forgetting to take your meds? Israeli firm creates nudging tool

MEDICAL MARIJUANA LAWS IN 2018 COULD HELP ISRAEL BECOME A GLOBAL SUPERPOWER

Americans may soon be able to get medical marijuana from an unlikely drug dealer: Israel. Bloomberg reported Thursday that 2018 could be a big year for the country’s quest to become a global pot provider. Israel’s government is on track to pass regulations that would allow growers to export their products, and at least one company—Breath of Life Pharma—is [...]

By | 2017-11-15T14:13:56+00:00 November 15th, 2017|Blog|Comments Off on MEDICAL MARIJUANA LAWS IN 2018 COULD HELP ISRAEL BECOME A GLOBAL SUPERPOWER

Israel’s Nextar setting up medical cannabis incubator

A cooperation agreement has been signed with an Australian medical cannabis investment fund. Nextar, one of Israel's leading companies in the development of formulations for drugs, is expanding into medical cannabis formulations. The company will invest in setting up a development center and incubator for medical cannabis products. The incubator, to be called Nextage, will [...]

By | 2017-11-15T12:25:40+00:00 November 15th, 2017|Blog|Comments Off on Israel’s Nextar setting up medical cannabis incubator

#Biomed2018: Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion

 Congratulations to Dr. Arie Belldegrun and Prof. Zelig Eshhar for an incredible achievement! Gilead Sciences agreed to 29 percent premium, which shrank fast in pretrading, despite biotech company Kite Pharma's low revenues, heavy R&D spending and losses Yoram Gabison Aug 29, 2017 The headquarters of Gilead Sciences in Foster City, California Credit: Eric Risberg, AP The almost [...]

By | 2017-08-29T09:06:46+00:00 August 29th, 2017|Blog|Comments Off on #Biomed2018: Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion

Mysterious Pediatric Neurological Disease Traced to a Single Gene Error

For the first time, scientists at Hebrew University of Jerusalem traced a rare neurological disorder in children to an error in a single gene. Led by Professor Orly Elpeleg, a geneticist and professor of Pediatrics at Hebrew University’s Faculty of Medicine, the international research team used deep sequencing technology to find a genetic anomaly representing [...]

By | 2017-08-20T10:24:06+00:00 August 20th, 2017|Blog|Comments Off on Mysterious Pediatric Neurological Disease Traced to a Single Gene Error

#Trump’s FDA Commissioner on #Drug #Prices, #Regulations, #Science

U.S. Food and Drug Administration Commissioner Scott Gottlieb spoke with Bloomberg News about drug pricing, new medicine and regulations. This transcript of the interview has been edited for clarity and length. Bloomberg: What’s the FDA’s role to play in drug pricing and what can the agency do, given that it hasn’t traditionally had a mandate to address [...]

By | 2017-07-31T07:03:41+00:00 July 31st, 2017|Blog|Comments Off on #Trump’s FDA Commissioner on #Drug #Prices, #Regulations, #Science